Fig. 3From: Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling studyEvaluation of the effectiveness of potential antiviral treatments (with highest TAR reduction in each age group). a ≤ 14 years; b15–44 years; c 45–64 years; d ≥ 65 yearsBack to article page